| COVID-19–associated mucormycosis: a systematic review and meta-analysis of 958 cases L Özbek, U Topçu, M Manay, BH Esen, SN Bektas, S Aydın, B Özdemir, ... Clinical Microbiology and Infection 29 (6), 722-731, 2023 | 63 | 2023 |
| Klotho: a potential therapeutic target in aging and neurodegeneration beyond chronic kidney disease—a comprehensive review from the ERA CKD-MBD working group M Kanbay, S Copur, L Ozbek, A Mutlu, D Cejka, P Ciceri, M Cozzolino, ... Clinical Kidney Journal 17 (1), sfad276, 2024 | 14 | 2024 |
| The challenges in the monitoring of infectious diseases after the earthquake in Türkiye in 2023 Ö Ergönül, Ş Keske, A Ksinzik, M Güldan, L Özbek, A Azap, ... The Lancet Infectious Diseases 23 (11), e482-e488, 2023 | 12 | 2023 |
| Understanding the role of sex hormones in Cardiovascular kidney metabolic syndrome: toward personalized therapeutic approaches M Guldan, S Unlu, SM Abdel-Rahman, L Ozbek, A Gaipov, A Covic, ... Journal of clinical medicine 13 (15), 4354, 2024 | 5 | 2024 |
| Proximal tubule hypertrophy and hyperfunction: a novel pathophysiological feature in disease states M Kanbay, S Copur, M Guldan, L Ozbek, A Hatipoglu, A Covic, ... Clinical Kidney Journal, sfae195, 2024 | 3 | 2024 |
| Native nephrectomy in polycystic kidney disease patients on transplant lists: how and when? S Copur, L Ozbek, M Guldan, AU Topcu, M Kanbay Journal of Nephrology, 1-13, 2024 | 3 | 2024 |
| Imlifidase in kidney transplantation M Kanbay, S Copur, M Guldan, AU Topcu, L Ozbek, B Hasbal, C Süsal, ... Clinical Kidney Journal 17 (3), sfae033, 2024 | 3 | 2024 |
| Exploring the nexus: The place of kidney diseases within the cardiovascular-kidney-metabolic syndrome spectrum M Kanbay, M Guldan, L Ozbek, S Copur, AS Covic, A Covic European journal of internal medicine, 2024 | 2 | 2024 |
| An update review of post‐transplant diabetes mellitus: Concept, risk factors, clinical implications and management M Kanbay, S Copur, AU Topçu, M Guldan, L Ozbek, A Gaipov, C Ferro, ... Diabetes, Obesity and Metabolism, 2024 | 2 | 2024 |
| Exploring Adiposity and Chronic Kidney Disease: Clinical Implications, Management Strategies, Prognostic Considerations L Ozbek, SM Abdel-Rahman, S Unlu, M Guldan, S Copur, A Burlacu, ... Medicina 60 (10), 1668, 2024 | 1 | 2024 |
| The association between klotho and kidney and cardiovascular outcomes: a comprehensive systematic review and meta-analysis M Kanbay, C Brinza, L Ozbek, M Guldan, U Sisman, S Copur, A Covic, ... Clinical Kidney Journal 17 (9), sfae255, 2024 | 1 | 2024 |
| Prognostic impact of post-transplant diabetes mellitus in kidney allograft recipients: a meta-analysis M Kanbay, D Siriopol, M Guldan, L Ozbek, AU Topcu, I Siriopol, K Tuttle Nephrology Dialysis Transplantation, gfae185, 2024 | 1 | 2024 |
| Metabolically healthy obesity and chronic kidney disease risk: exploring the dynamics. M Guldan, L Ozbek, AU Topcu, A Covic, M Kanbay Panminerva Medica 66 (3), 293-308, 2024 | 1 | 2024 |
| A meta-analysis of 556 individual COVID-19-associated mucormycosis cases: learning from the pandemic L Özbek, U Topçu, M Manay, BH Esen, SN Bektas, S Aydın, B Özdemir, ... Available at SSRN 4174291, 2022 | 1 | 2022 |
| Glucagon and glucagon‐like peptide‐1 dual agonist therapy: A possible future towards fatty kidney disease M Kanbay, S Copur, M Guldan, L Ozbek, F Mallamaci, C Zoccali European Journal of Clinical Investigation 55 (1), e14330, 2025 | | 2025 |
| Unveiling the intricacies of chronic kidney disease: From ocular manifestations to therapeutic frontiers M Kanbay, M Guldan, L Ozbek, S Copur, F Mallamaci, C Zoccali European Journal of Clinical Investigation 55 (1), e14324, 2025 | | 2025 |
| Post-transplant IgA nephropathy: a rapidly evolving field of kidney transplant medicine M Kanbay, L Ozbek, M Guldan, S Copur, J Barratt Journal of Nephrology, 1-10, 2024 | | 2024 |
| Long-term impact of pregnancy on mortality and graft outcomes in kidney transplant recipients: a systematic review and meta-analysis M Kanbay, C Brinza, L Ozbek, S Unlu, SM Abdel-Rahman, M Guldan, ... | | 2024 |
| Patient-specific multifactorial mortality risk assessment using classification and regression tree analysis in the context of ambulatory blood pressure monitoring BT Çetin, NB Hasbal, E Cevik, OE Sahin, M Akyol, Z Kalay, D Ucku, ... Journal of Nephrology, 1-9, 2024 | | 2024 |
| Characterizing immune checkpoint inhibitor-related cutaneous adverse reactions: A comprehensive analysis of FDA adverse event reporting system (FAERS) database BH Esen, L Özbek, S Oğuz, F Selçukbiricik Heliyon 10 (13), 2024 | | 2024 |
